FdaApplication
ANDA 212264
Identifiers
- fda_app_no: ANDA212264
Properties
| Property | Value |
|---|---|
| applicant_name | PRINSTON PHARMA INC |
| application_type | ANDA |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EMPAGLIFLOZIN AND LINAGLIPTIN | EMPAGLIFLOZIN; LINAGLIPTIN | 25MG;5MG | TABLET;ORAL |
1 product